GATINEAU, Quebec, May 07, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE:THCX)
today announced that the Company will host an investor day on May 16, 2018 at the JW Marriott Essex House in New York City
beginning at 10 am. The Company’s management team including, Sebastien St-Louis, CEO, Ed Chaplin, CFO, James McMillan, VP
Business Development, and Dr. Terry Lake, VP of Corporate Social Responsibility will attend and speak about Hydropothecary’s
current expansion plans, SAQ contract and product innovation.
Interested investors should contact Jennifer Smith at invest@thehydropothecary.com for further registration
information.
About The Hydropothecary Corporation
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada
under the Access to Cannabis for Medical Purposes Regulations. Hydropothecary creates award-winning innovative, easy to use and
easy to understand products. Hydropothecary is rapidly increasing its production capacity in the lead-up to recreational adult-use
cannabis. Headquartered in Quebec, Hydropothecary is one of the lowest-cost producers in the country.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Investor Relations:
Jennifer Smith
Manager of Financial Reporting and Investor Relations
1-866-438-THCX (8429)
invest@THCX.com
www.THCX.com
Media Relations:
Shawn Lyons
Media Relations
Shawn.lyons@thehydropothecary.com
Director
Adam Miron
819-639-5498
